These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34638539)

  • 1. Severity of COVID-19 Patients Predicted by Serum Sphingolipids Signature.
    Torretta E; Garziano M; Poliseno M; Capitanio D; Biasin M; Santantonio TA; Clerici M; Lo Caputo S; Trabattoni D; Gelfi C
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive metabolic modulations of sphingolipids are promising severity indicators in COVID-19.
    Uranbileg B; Isago H; Nakayama H; Jubishi D; Okamoto K; Sakai E; Kubota M; Tsutsumi T; Moriya K; Kurano M
    FASEB J; 2024 Jul; 38(14):e23827. PubMed ID: 39012295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Race disparity in blood sphingolipidomics associated with lupus cardiovascular comorbidity.
    Hammad SM; Hardin JR; Wilson DA; Twal WO; Nietert PJ; Oates JC
    PLoS One; 2019; 14(11):e0224496. PubMed ID: 31747417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ramadan intermittent fasting is associated with ameliorated inflammatory markers and improved plasma sphingolipids/ceramides in subjects with obesity: lipidomics analysis.
    Madkour MI; Islam MT; Tippetts TS; Chowdhury KH; Lesniewski LA; Summers SA; Zeb F; Abdelrahim DN; AlKurd R; Khraiwesh HM; AbuShihab KH; AlBakri A; Obaideen K; Faris ME
    Sci Rep; 2023 Oct; 13(1):17322. PubMed ID: 37833312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic modulations of urinary sphingolipid and glycerophospholipid levels in COVID-19 and correlations with COVID-19-associated kidney injuries.
    Kurano M; Jubishi D; Okamoto K; Hashimoto H; Sakai E; Morita Y; Saigusa D; Kano K; Aoki J; Harada S; Okugawa S; Doi K; Moriya K; Yatomi Y
    J Biomed Sci; 2022 Nov; 29(1):94. PubMed ID: 36357929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of lipid metabolism provide serologic biomarkers for the detection of asymptomatic versus symptomatic COVID-19 patients.
    Janneh AH; Kassir MF; Dwyer CJ; Chakraborty P; Pierce JS; Flume PA; Li H; Nadig SN; Mehrotra S; Ogretmen B
    Sci Rep; 2021 Jul; 11(1):14232. PubMed ID: 34244584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Sphingolipidomic Analysis in Acne Vulgaris Patients.
    Kaya S; Aslan İ; Kıraç E; Karaarslan T; Aslan M
    Ann Clin Lab Sci; 2019 Mar; 49(2):242-248. PubMed ID: 31028071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered Levels of Serum Ceramide, Sphingosine and Sphingomyelin Are Associated with Colorectal Cancer: A Retrospective Pilot Study.
    Separovic D; Shields AF; Philip PA; Bielawski J; Bielawska A; Pierce JS; Tarca AL
    Anticancer Res; 2017 Mar; 37(3):1213-1218. PubMed ID: 28314284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic modulations of sphingolipids and glycerophospholipids in COVID-19.
    Kurano M; Okamoto K; Jubishi D; Hashimoto H; Sakai E; Saigusa D; Kano K; Aoki J; Harada S; Okugawa S; Doi K; Moriya K; Yatomi Y
    Clin Transl Med; 2022 Oct; 12(10):e1069. PubMed ID: 36214754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serine palmitoyl-CoA transferase (SPT) deficiency and sphingolipid levels in mice.
    Hojjati MR; Li Z; Jiang XC
    Biochim Biophys Acta; 2005 Oct; 1737(1):44-51. PubMed ID: 16216550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomic profiling of sphingolipids in human glioma cell lines by liquid chromatography tandem mass spectrometry.
    Sullards MC; Wang E; Peng Q; Merrill AH
    Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):789-97. PubMed ID: 14528916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingolipids signature in plasma and tissue as diagnostic and prognostic tools in oral squamous cell carcinoma.
    Faedo RR; da Silva G; da Silva RM; Ushida TR; da Silva RR; Lacchini R; Matos LL; Kowalski LP; Lopes NP; Leopoldino AM
    Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Jan; 1867(1):159057. PubMed ID: 34655810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma lipidomic analysis of sphingolipids in patients with large artery atherosclerosis cerebrovascular disease and cerebral small vessel disease.
    You Q; Peng Q; Yu Z; Jin H; Zhang J; Sun W; Huang Y
    Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32830858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Sphingomyelin Disturbances: Unveiling Its Dual Role as a Crucial Immunopathological Factor and a Severity Prognostic Biomarker in COVID-19.
    Toro DM; da Silva-Neto PV; de Carvalho JCS; Fuzo CA; Pérez MM; Pimentel VE; Fraga-Silva TFC; Oliveira CNS; Caruso GR; Vilela AFL; Nobre-Azevedo P; Defelippo-Felippe TV; Argolo JGM; Degiovani AM; Ostini FM; Feitosa MR; Parra RS; Vilar FC; Gaspar GG; Rocha JJRD; Feres O; Costa GP; Maruyama SRC; Russo EMS; Fernandes APM; Santos IKFM; Malheiro A; Sadikot RT; Bonato VLD; Cardoso CRB; Dias-Baruffi M; Trapé ÁA; Faccioli LH; Sorgi CA; ImmunoCovid Consortium Group
    Cells; 2023 Jul; 12(15):. PubMed ID: 37566018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-scale lipidomics identifies associations between plasma sphingolipids and T2DM incidence.
    Chew WS; Torta F; Ji S; Choi H; Begum H; Sim X; Khoo CM; Khoo EYH; Ong WY; Van Dam RM; Wenk MR; Tai ES; Herr DR
    JCI Insight; 2019 Jun; 5(13):. PubMed ID: 31162145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased Serum Levels of Sphingomyelins and Ceramides in Sickle Cell Disease Patients.
    Aslan M; Kıraç E; Kaya S; Özcan F; Salim O; Küpesiz OA
    Lipids; 2018 Mar; 53(3):313-322. PubMed ID: 29663386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum sphingolipids: relationships to insulin sensitivity and changes with exercise in humans.
    Bergman BC; Brozinick JT; Strauss A; Bacon S; Kerege A; Bui HH; Sanders P; Siddall P; Kuo MS; Perreault L
    Am J Physiol Endocrinol Metab; 2015 Aug; 309(4):E398-408. PubMed ID: 26126684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic processing of gangliosides by human fibroblasts in culture--formation and recycling of separate pools of sphingosine.
    Chigorno V; Riva C; Valsecchi M; Nicolini M; Brocca P; Sonnino S
    Eur J Biochem; 1997 Dec; 250(3):661-9. PubMed ID: 9461288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of sphingolipid metabolism: from synthesis to breakdown.
    Gault CR; Obeid LM; Hannun YA
    Adv Exp Med Biol; 2010; 688():1-23. PubMed ID: 20919643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma sphingolipids associated with chronic obstructive pulmonary disease phenotypes.
    Bowler RP; Jacobson S; Cruickshank C; Hughes GJ; Siska C; Ory DS; Petrache I; Schaffer JE; Reisdorph N; Kechris K
    Am J Respir Crit Care Med; 2015 Feb; 191(3):275-84. PubMed ID: 25494452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.